(Q39484193)

12 September 2017

title

SV40 T/t-common polypeptide inhibits angiogenesis and growth of HER2-overexpressing human ovarian cancer (English)

1 reference

12 September 2017

1 reference

1 reference

S-P Hsueh

1

1 reference

12 September 2017

W-B Hsu

series ordinal

2

1 reference

12 September 2017

C-C Wen

series ordinal

3

1 reference

12 September 2017

W-B Wang

series ordinal

4

1 reference

12 September 2017

publication date

26 August 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

18

1 reference

12 September 2017

issue

12

1 reference

12 September 2017

page(s)

859-870

1 reference

https://scigraph.springernature.com/pub.10.1038/cgt.2011.55

12 September 2017

exact match

0 references

cites work

ErbB receptors: directing key signaling networks throughout life

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Signal transduction and oncogenesis by ErbB/HER receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

The biology of erbB-2/neu/HER-2 and its role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

ErbB-2 amplification inhibits down-regulation and induces constitutive activation of both ErbB-2 and epidermal growth factor receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Role of angiogenesis in tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Prognostic, predictive and therapeutic implications of HER2 in invasive epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Beyond chemotherapy: targeted therapies in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Promising molecular targets in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNA against Her-2/neu gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Tumour biology: herceptin acts as an anti-angiogenic cocktail.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

The N-terminal common domain of simian virus 40 large T and small t antigens acts as a transformation suppressor of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

SV40 T/t-common polypeptide specifically induces apoptosis in human cancer cells that overexpress HER2/neu

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Epstein-Barr virus nuclear antigen 2 disrupts mitotic checkpoint and causes chromosomal instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Antiangiogenic drugs in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Suppression of tumor growth through disruption of hypoxia-inducible transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Molecular crosstalk between p70S6k and MAPK cell signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Translational control by MAPK signaling in long-term synaptic plasticity and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: their implication in vascular endothelial growth factor gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Identification of MAPK phosphorylation sites and their role in the localization and activity of hypoxia-inducible factor-1alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

inferred from DOI database lookup

7 January 2021

based on heuristic

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

inferred from DOI database lookup

7 January 2021

based on heuristic

A hypoxia-independent hypoxia-inducible factor-1 activation pathway induced by phosphatidylinositol-3 kinase/Akt in HER2 overexpressing cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.55

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CGT.2011.55

1 reference

12 September 2017

1 reference